May 26, 2020
Otsuka Pharmaceutical said on May 25 that its Russian partner R-Pharm Group received approval in Russia for the oral anti-tuberculosis (TB) drug Deltyba (delamanid). Otsuka concluded a license pact with R-Pharm in 2017, granting the partner commercialization rights in Russia...read more